Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis
Ask AI
Have a question about this topic?
Ask the article assistant — answers are based on this study's abstract.
Log in to ask a question
Free account required